Juno Theraputics completed its IPO
On Dec. 23, 2014, Juno Therapeutics announced the closing of its initial public offering of 12.7 million shares…
On Dec. 23, 2014, Juno Therapeutics announced the closing of its initial public offering of 12.7 million shares…
On Dec. 23, 2014, Novo Nordisk the FDA approved a formulation of Novo Nordiskメs diabetes drug, liraglutide, for…
On Dec. 22, 2014, BioCryst Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) had approved RAPIVAB (peramivir…
On Dec. 18, 2014, the University of Nebraska Medical Center announced it had received a $1.3 million gift…
On Dec. 11, 2014, University of Minnesota mourned loss of Lee Wattenberg, M.D., recognized as the ‘father of…
On Dec. 12, 2014, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had approved the supplemental…
On Dec. 11, 2014, Merck announced that the FDA had approved GARDASILᆴ9 (Human Papillomavirus 9-valent Vaccine, Recombinant), Merckメs…
On Dec. 10, 2014, Dr. Andras Nagy, from the University of Toronto and leader of Project Grandiose, announced…
On Dec. 9, 2014, the Biotechnology Industry Organization (BIO) announced that Debbie Yaver, Novozymes’ director of expression technology,…
On Dec. 8, 2014, philanthropist and entrepreneur Paul G. Allen announced a commitment of $100 million to create…
On Dec. 3, 2014, the Fred & Pamela Buffett Cancer Center at the University of Nebraska Medical Center…
On Dec. 3, 2014, Fred Eshelman, CEO and founder of Wilmington-based PPD Inc. and a member of the…
On Nov. 27, 2014, two papers were published in Science that announced the completion and preliminary analyses of…
On Nov. 21, 2014, funding was announced for the TEC Health Accelerator for Alberta, to assist promising startup…
On Nov. 5, 2014, the Ford Family Foundation announced a $5 million grant to the Knight Cancer Institute…
On Oct. 29, 2014, Pfizer announced the FDA has granted accelerated approval of TRUMENBAᆴ (meningococcal group B vaccine)…
On Oct. 23, 2014, philanthropist Paul G. Allen donated $100 million to fight Ebola and called on the…
On Oct. 21, 2014, the Jackson Laboratory (JAX) announced that technology investor David Roux and his wife Barbara…
On Oct. 20, 2014, Oregon Health & Science University’s Vaccine & Gene Therapy Institute (OHSU) announced it was…
On Oct. 15, 2014, the University of Iowa ushered in a new age of accelerated research in biomedicine…
On Oct. 15, 2014, Genentech drug Esbriet (pirfenidone) was approved by the U.S. Food and Drug Administration (FDA)…
On Oct. 13, 2014, the Nebraska Medical Center, Bellevue Medical Center and UNMC Physicians – once three separate…
On Oct. 13, 2014, the University of Minnesota’s Children’s Hospital was renamed the University of Minnesota Masonic Children’s…
On Oct. 13, 2014, the International Society on Thrombosis and Haemostasis launched the annual World Thrombosis Day World…
On Oct. 9, 2014, a landmark study led by Douglas Melton from Harvard University successfully generated functional, mature human…
On Oct. 8, 2014, Ohio State University, Cardinal Health and State of Ohio Third Frontier Commission announced completion…
On Oct. 7, 2014, The Jackson Laboratory opened a state-of-the-art genomics research center on the campus of the…
On Oct. 6, 2014, May-Britt Moser won a share of the 2014 Nobel Prize in Physiology or Medicine…
On Oct. 5, 2014, BD and CareFusion announced a definitive agreement whereby BD acquired CareFusion for $58.00 per…
On Sept. 30, 2014, the Centers for Disease Control and Prevention confirmed that Eric Duncan, a Liberian national…